DERIVATIVE OF INSULIN OR ITS PHYSIOLOGICALLY ACCEPTABLE SALT, PRECURSOR OF INSULIN DERIVATIVE, DNA SEQUENCE ENCODING PRECURSOR, EXPRESSION VECTOR COMPRISING MENTIONED DNA SEQUENCE, SUBSTRATE TRANSFORMED WITH MENTIONED EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION WITH REDUCING AND REGULATING BLOOD GLUCOSE LEVEL EFFECTIVENESS, RESPECTIVELY

FIELD: medicine, endocrinology, molecular biology, genetic engineering, medicinal industry. SUBSTANCE: invention relates to derivative of insulin or its physiologically acceptable salt with accelerated onset effect as compared with human insulin. In this insulin derivative asparagines (Asn) in posit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GAJZEN KARL, KHABERMANN PAUL, ZAJPKE GERKHARD, EHRTL' JOKHANN
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GAJZEN KARL
KHABERMANN PAUL
ZAJPKE GERKHARD
EHRTL' JOKHANN
description FIELD: medicine, endocrinology, molecular biology, genetic engineering, medicinal industry. SUBSTANCE: invention relates to derivative of insulin or its physiologically acceptable salt with accelerated onset effect as compared with human insulin. In this insulin derivative asparagines (Asn) in position B3 of chain B is replaced for natural basic amino acid residue, and at least one amino acid residue in positions B27, B28 or B29 of chain B is replaced for another natural neutral or acid amino acid residue being asparagines (Asn) in position A21 of chain A can be replaced for Asp, Gly, Ser, Thr or Ala and phenylalanine (Phe) in position B1 of chain B and amino acid residue in position B30 of chain B can absent. Invention describes also DNA sequences encoding precursor of insulin derivative, expression vector comprising this DNA and also strains expressing insulin precursor and pharmaceutical composition with reducing and regulating blood glucose level effectiveness, respectively. The advantage of invention involves the development of preparation with accelerated onset of effect. EFFECT: valuable properties of composition. 23 cl, 6 tbl, 1 dwg, 8 ex
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2207874C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2207874C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2207874C23</originalsourceid><addsrcrecordid>eNqNj0FLA0EMhevBg6j_IT9gBVmFep1msrsD2Zl1klntqRRZT6KF-v8xa4VWvHjJ8JjvvZdcnKmnHEanYSRIDYQohUOElCGowNCtJSRObUDHvAaHSIO6FROIY61gyIQli-En5mNkBT46EHosFJHARvIhtkdbBfRsQqwlwkioloSpH3KQmespqv2Q_5VTgZSVaHZKYDNKk3JvzFPQ7sTyJ9nW7VzuHVLR-aDvpiRh5g_mTL7gXOyiN9EWtjNMrjglDy0XTELANBIDNY2l2pHRSiqjZThoXl8tzl-3b_vp-ue9XEBDit3NtPvYTPvd9mV6nz43udT17fJheY_13T-QL2vxdqU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DERIVATIVE OF INSULIN OR ITS PHYSIOLOGICALLY ACCEPTABLE SALT, PRECURSOR OF INSULIN DERIVATIVE, DNA SEQUENCE ENCODING PRECURSOR, EXPRESSION VECTOR COMPRISING MENTIONED DNA SEQUENCE, SUBSTRATE TRANSFORMED WITH MENTIONED EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION WITH REDUCING AND REGULATING BLOOD GLUCOSE LEVEL EFFECTIVENESS, RESPECTIVELY</title><source>esp@cenet</source><creator>GAJZEN KARL ; KHABERMANN PAUL ; ZAJPKE GERKHARD ; EHRTL' JOKHANN</creator><creatorcontrib>GAJZEN KARL ; KHABERMANN PAUL ; ZAJPKE GERKHARD ; EHRTL' JOKHANN</creatorcontrib><description>FIELD: medicine, endocrinology, molecular biology, genetic engineering, medicinal industry. SUBSTANCE: invention relates to derivative of insulin or its physiologically acceptable salt with accelerated onset effect as compared with human insulin. In this insulin derivative asparagines (Asn) in position B3 of chain B is replaced for natural basic amino acid residue, and at least one amino acid residue in positions B27, B28 or B29 of chain B is replaced for another natural neutral or acid amino acid residue being asparagines (Asn) in position A21 of chain A can be replaced for Asp, Gly, Ser, Thr or Ala and phenylalanine (Phe) in position B1 of chain B and amino acid residue in position B30 of chain B can absent. Invention describes also DNA sequences encoding precursor of insulin derivative, expression vector comprising this DNA and also strains expressing insulin precursor and pharmaceutical composition with reducing and regulating blood glucose level effectiveness, respectively. The advantage of invention involves the development of preparation with accelerated onset of effect. EFFECT: valuable properties of composition. 23 cl, 6 tbl, 1 dwg, 8 ex</description><edition>7</edition><language>eng ; rus</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030710&amp;DB=EPODOC&amp;CC=RU&amp;NR=2207874C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030710&amp;DB=EPODOC&amp;CC=RU&amp;NR=2207874C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GAJZEN KARL</creatorcontrib><creatorcontrib>KHABERMANN PAUL</creatorcontrib><creatorcontrib>ZAJPKE GERKHARD</creatorcontrib><creatorcontrib>EHRTL' JOKHANN</creatorcontrib><title>DERIVATIVE OF INSULIN OR ITS PHYSIOLOGICALLY ACCEPTABLE SALT, PRECURSOR OF INSULIN DERIVATIVE, DNA SEQUENCE ENCODING PRECURSOR, EXPRESSION VECTOR COMPRISING MENTIONED DNA SEQUENCE, SUBSTRATE TRANSFORMED WITH MENTIONED EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION WITH REDUCING AND REGULATING BLOOD GLUCOSE LEVEL EFFECTIVENESS, RESPECTIVELY</title><description>FIELD: medicine, endocrinology, molecular biology, genetic engineering, medicinal industry. SUBSTANCE: invention relates to derivative of insulin or its physiologically acceptable salt with accelerated onset effect as compared with human insulin. In this insulin derivative asparagines (Asn) in position B3 of chain B is replaced for natural basic amino acid residue, and at least one amino acid residue in positions B27, B28 or B29 of chain B is replaced for another natural neutral or acid amino acid residue being asparagines (Asn) in position A21 of chain A can be replaced for Asp, Gly, Ser, Thr or Ala and phenylalanine (Phe) in position B1 of chain B and amino acid residue in position B30 of chain B can absent. Invention describes also DNA sequences encoding precursor of insulin derivative, expression vector comprising this DNA and also strains expressing insulin precursor and pharmaceutical composition with reducing and regulating blood glucose level effectiveness, respectively. The advantage of invention involves the development of preparation with accelerated onset of effect. EFFECT: valuable properties of composition. 23 cl, 6 tbl, 1 dwg, 8 ex</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNj0FLA0EMhevBg6j_IT9gBVmFep1msrsD2Zl1klntqRRZT6KF-v8xa4VWvHjJ8JjvvZdcnKmnHEanYSRIDYQohUOElCGowNCtJSRObUDHvAaHSIO6FROIY61gyIQli-En5mNkBT46EHosFJHARvIhtkdbBfRsQqwlwkioloSpH3KQmespqv2Q_5VTgZSVaHZKYDNKk3JvzFPQ7sTyJ9nW7VzuHVLR-aDvpiRh5g_mTL7gXOyiN9EWtjNMrjglDy0XTELANBIDNY2l2pHRSiqjZThoXl8tzl-3b_vp-ue9XEBDit3NtPvYTPvd9mV6nz43udT17fJheY_13T-QL2vxdqU</recordid><startdate>20030710</startdate><enddate>20030710</enddate><creator>GAJZEN KARL</creator><creator>KHABERMANN PAUL</creator><creator>ZAJPKE GERKHARD</creator><creator>EHRTL' JOKHANN</creator><scope>EVB</scope></search><sort><creationdate>20030710</creationdate><title>DERIVATIVE OF INSULIN OR ITS PHYSIOLOGICALLY ACCEPTABLE SALT, PRECURSOR OF INSULIN DERIVATIVE, DNA SEQUENCE ENCODING PRECURSOR, EXPRESSION VECTOR COMPRISING MENTIONED DNA SEQUENCE, SUBSTRATE TRANSFORMED WITH MENTIONED EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION WITH REDUCING AND REGULATING BLOOD GLUCOSE LEVEL EFFECTIVENESS, RESPECTIVELY</title><author>GAJZEN KARL ; KHABERMANN PAUL ; ZAJPKE GERKHARD ; EHRTL' JOKHANN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2207874C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2003</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>GAJZEN KARL</creatorcontrib><creatorcontrib>KHABERMANN PAUL</creatorcontrib><creatorcontrib>ZAJPKE GERKHARD</creatorcontrib><creatorcontrib>EHRTL' JOKHANN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GAJZEN KARL</au><au>KHABERMANN PAUL</au><au>ZAJPKE GERKHARD</au><au>EHRTL' JOKHANN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DERIVATIVE OF INSULIN OR ITS PHYSIOLOGICALLY ACCEPTABLE SALT, PRECURSOR OF INSULIN DERIVATIVE, DNA SEQUENCE ENCODING PRECURSOR, EXPRESSION VECTOR COMPRISING MENTIONED DNA SEQUENCE, SUBSTRATE TRANSFORMED WITH MENTIONED EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION WITH REDUCING AND REGULATING BLOOD GLUCOSE LEVEL EFFECTIVENESS, RESPECTIVELY</title><date>2003-07-10</date><risdate>2003</risdate><abstract>FIELD: medicine, endocrinology, molecular biology, genetic engineering, medicinal industry. SUBSTANCE: invention relates to derivative of insulin or its physiologically acceptable salt with accelerated onset effect as compared with human insulin. In this insulin derivative asparagines (Asn) in position B3 of chain B is replaced for natural basic amino acid residue, and at least one amino acid residue in positions B27, B28 or B29 of chain B is replaced for another natural neutral or acid amino acid residue being asparagines (Asn) in position A21 of chain A can be replaced for Asp, Gly, Ser, Thr or Ala and phenylalanine (Phe) in position B1 of chain B and amino acid residue in position B30 of chain B can absent. Invention describes also DNA sequences encoding precursor of insulin derivative, expression vector comprising this DNA and also strains expressing insulin precursor and pharmaceutical composition with reducing and regulating blood glucose level effectiveness, respectively. The advantage of invention involves the development of preparation with accelerated onset of effect. EFFECT: valuable properties of composition. 23 cl, 6 tbl, 1 dwg, 8 ex</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2207874C2
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title DERIVATIVE OF INSULIN OR ITS PHYSIOLOGICALLY ACCEPTABLE SALT, PRECURSOR OF INSULIN DERIVATIVE, DNA SEQUENCE ENCODING PRECURSOR, EXPRESSION VECTOR COMPRISING MENTIONED DNA SEQUENCE, SUBSTRATE TRANSFORMED WITH MENTIONED EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION WITH REDUCING AND REGULATING BLOOD GLUCOSE LEVEL EFFECTIVENESS, RESPECTIVELY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T15%3A38%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GAJZEN%20KARL&rft.date=2003-07-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2207874C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true